Silvana Novelli, Leyre Bento, Irene Garcia, Laura Prieto, Lucía López, Gonzalo Gutierrez, Rafael Hernani, Ariadna Pérez, Albert Esquirol, Carlos Solano, Mariana Bastos, Nieves Dorado, Nancy Rodríguez, Guillermo Rodríguez, Jose L Piñana, Juan Montoro, Pilar Herrera, Alejandro Luna, Rocío Parody, Carmen Martín, Estefanía García, Oriana López, Inmaculada Heras, Joud Zanabili, Jose M Moraleda, Lucrecia Yañez, Antonio Gutierrez, Teresa Zudaire, Raúl Córdoba, Rosario Varela, Christelle Ferra, Joaquin Martínez, Carmen Martínez, Eva Gonzalez-Barca, Rodrigo Martino, Dolores Caballero
Despite advances in understanding the biology of mature T and natural killer (NK)/T cell neoplasia, current therapies, even the most innovative ones, are still far from ensuring its cure. The only treatment to date that has been shown to control aggressive T cell neoplasms in the long term is allogeneic stem cell transplantation (alloSCT). We aim to report the results of alloSCT for advanced mature T and NK/T neoplasias performed in centers from our national GELTAMO/GETH (Grupo Español de Linfoma y Trasplante de Médula Ósea/Grupo Español de Trasplante Hematopoyético y Terapia Celular) over the past 25 years...
June 2021: Transplantation and cellular therapy